Office of the Director, National Institutes of Health; Notice of Meeting, 7071-7072 [E9-2939]

Download as PDF Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2938 Filed 2–11–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. pwalker on PROD1PC71 with NOTICES Name of Committee: National Institute of General Medical Sciences Initial Review Group; Biomedical Research and Research Training Review Subcommittee A. Date: March 5, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Carole H. Latker, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18, Bethesda, MD 20892, (301) 594–2848, latkerc@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2943 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 17:03 Feb 11, 2009 Jkt 217001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel, PTSD Risk Assessment Tools. Date: March 9, 2009. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Serena P. Chu, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Rockville, MD 20892, 301–443–0004, sechu@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel, Comparative Interdisciplinary Studies of Cerebral Cortical Development. Date: March 18, 2009. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: Megan Libbey, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6148, MSC 9609, Rockville, MD 20852, 301–402–6807, libbeym@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel, EUREKA NIMH, NINDS, NIDA REVIEW. Date: April 2, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Westin Embassy Row, 2100 Massachusetts Ave., NW., Washington, DC 20008. Contact Person: Megan Libbey, PhD, Scientific Review Officer, Division of PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 7071 Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6148, MSC 9609, Rockville, MD 20852, 301–402–6807, libbeym@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2956 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. Date: March 3–4, 2009. Time: March 3, 2009, 8:30 a.m. to 5:30 p.m. Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as related data management activities. The meeting also includes a new protocol for X– SCID. Please check the meeting agenda at https://www4.od.nih.gov/oba/RAC/ meeting.htm for more information. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852. Time: March 4, 2009, 8:30 a.m. to 1 p.m. Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as a discussion of biosafety containment and practices for recombinant work with noncontemporary strains of influenza and highly pathogenic avian influenza strain H5N1. Please check the meeting agenda at https:// www4.od.nih.gov/oba/RAC/meeting.htm for more information. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room C, Rockville, MD 20852. E:\FR\FM\12FEN1.SGM 12FEN1 7072 Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices Contact Person: Lisa A. Parker, Advisory Committee Coordinator, Office of Science Policy, Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Suite 750–A1, Bethesda, MD 20892, 301–496–9838, parkerla@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:/// www4.od.nih.gov/oba/, where an agenda and any additional information for the meeting will be posted when available. OMB’s ‘‘Mandatory Information Requirements for Federal Assistance Program Announcements’’ (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected. pwalker on PROD1PC71 with NOTICES (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2939 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 17:03 Feb 11, 2009 Jkt 217001 DEPARTMENT OF HOMELAND SECURITY United States Immigration and Customs Enforcement Agency Information Collection Activities: New Information Collection; Comment Request ACTION: 60-Day Notice of New Information Collection; Form I–395, Affidavit in Lieu of Lost Receipt of Immigration and Customs Enforcement for Collateral Accepted as Security. The Department of Homeland Security, U.S. Immigration and Customs Enforcement (USICE), has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for sixty days until April 13, 2009. Written comments and suggestions regarding items contained in this notice, and especially with regard to the estimated public burden and associated response time should be directed to the Department of Homeland Security (DHS), Joseph M. Gerhart, Chief, Records Management Branch, U.S. Immigration and Customs Enforcement, 500 12th Street, SW., Room 3138, Washington, DC 20024; (202) 732–6337. Comments are encouraged and will be accepted for sixty days until April 13, 2009. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 (1) Type of Information Collection: New information collection. (2) Title of the Form/Collection: Affidavit in Lieu of Lost Receipt of Immigration and Customs Enforcement for Collateral Accepted as Security. (3) Agency Form Number, If Any, and the Applicable Component of the Department of Homeland Security Sponsoring the Collection: Form I–395, U.S. Immigration and Customs Enforcement. (4) Affected Public Who Will Be Asked or Required to Respond, as Well as a Brief Abstract: Primary: Individual or Households. When an individual posts an Immigration Bond in the form of cash, cashiers check, certified check or money order, he or she is issued a Receipt of Immigration Officer—U.S. Bonds or Cash, Accepted as Security on Immigration Bond (Form I–305). If the I–305 is lost the individual is permitted to complete the I–395 stating the reason for the loss of the original I–305. (5) An Estimate of the Total Number of Respondents and the Amount of Time Estimated for an Average Respondent to Respond: 12,500 responses at 30 minutes (.50 hours) per response. (6) An Estimate of the Total Public Burden (in Hours) Associated with the Collection: 6,250 annual burden hours. Comments and/or questions; requests for a copy of the proposed information collection instrument, with instructions; or inquiries for additional information should be directed to: Joseph M. Gerhart, Chief, Records Management Branch, U.S. Immigration and Customs Enforcement, 500 12th Street, SW., Room 3138, Washington, DC 20024; (202) 732–6337. Dated: February 9, 2009. Joseph M. Gerhart, Chief, Records Management Branch, U.S. Immigration and Customs Enforcement, Department of Homeland Security. [FR Doc. E9–2984 Filed 2–11–09; 8:45 am] BILLING CODE 9111–28–P DEPARTMENT OF HOMELAND SECURITY United States Immigration and Customs Enforcement Agency Information Collection Activities: New Information Collection; Comment Request ACTION: 60-Day Notice of New Information Collection; Form I–312, Designation of Attorney in Fact. The Department of Homeland Security, U.S. Immigration and Customs Enforcement (USICE), has submitted the E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 74, Number 28 (Thursday, February 12, 2009)]
[Notices]
[Pages 7071-7072]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2939]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: March 3-4, 2009.
    Time: March 3, 2009, 8:30 a.m. to 5:30 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols as well as related 
data management activities. The meeting also includes a new protocol 
for X-SCID. Please check the meeting agenda at https://
www4.od.nih.gov/oba/RAC/meeting.htm for more information.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Conference Room C, Rockville, MD 20852.
    Time: March 4, 2009, 8:30 a.m. to 1 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols as well as a 
discussion of biosafety containment and practices for recombinant 
work with non-contemporary strains of influenza and highly 
pathogenic avian influenza strain H5N1. Please check the meeting 
agenda at https://www4.od.nih.gov/oba/RAC/meeting.htm for more 
information.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Conference Room C, Rockville, MD 20852.

[[Page 7072]]

    Contact Person: Lisa A. Parker, Advisory Committee Coordinator, 
Office of Science Policy, Office of Biotechnology Activities, 
National Institutes of Health, 6705 Rockledge Drive, Suite 750-A1, 
Bethesda, MD 20892, 301-496-9838, parkerla@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https:///www4.od.nih.gov/oba/, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)
    Dated: February 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E9-2939 Filed 2-11-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.